LONDON—Drug-resistant tuberculosis is spreading even faster than medical experts had feared, the World Health Organization warned in report issued Tuesday. The rate of TB patients infected with the drug-resistant strain topped 20 percent in some countries, the highest ever recorded, the U.N. agency said. "Ten years ago, it would have been unthinkable to see rates like this," said Dr. Mario Raviglione, director of WHO's "Stop TB" department. "This demonstrates what happens when you keep making mistakes in TB treatment." Though the report is the largest survey of drug-resistant TB, based...
Apart from teeth, sharks have another tool to kill their prey, deadly bacteria
DNA India
DNA India
Washington, DC: Sharks’ finely serrated teeth and their ability to smell blood is fearsome enough, and now scientists have claimed that one can even get harmed by touching the skin of a shark—by bacterial...
New interest in a shelved `miracle' drug
The Miami Herald
The Miami Herald
WASHINGTON -- More than half a century ago, when antibiotics were transforming modern medicine, a now almost forgotten drug was hailed as something close to the miracle of miracles. Doctors rushed to prescribe it for an...
Now, computer program that can predict bacteria's moves
Newstrack India
Newstrack India
Washington, July 20 (ANI): Scientists are using computers to find how one strain of dangerous bacteria might mutate in the same way a master chess player tries to foresee an opponent's strategies. The predictive...
Now, computer programme that can predict bacteria''s moves
Deccan Chronicle
Deccan Chronicle
Now, computer programme that can predict bacteria''s moves Share ARTICLEURL Washington, July 20: Scientists are using computers to find how one strain of dangerous bacteria might mutate in the same way a master...
Computer program predicts MRSA's next move
PhysOrg
PhysOrg
This image is a visualization of the 3-D crystal structure of the top-scoring DHFR protein mutant, determined from experimental data. DHFR is a likely molecule for attack by a drug to stop MRSA bacteria infections. The...
Docs Reconsider Old Antibiotics
Hartford Courant
Hartford Courant
Reporting from Washington — More than half a century ago, when antibiotics were transforming modern medicine, a now almost forgotten drug was hailed as something close to the miracle of miracles. Doctors rushed to...
Doctors' findings may fight drug-resistant TB
MSNBC
MSNBC
JOHANNESBURG, South Africa — Doctors said Thursday that a genome for one strain of an extensively drug-resistant tuberculosis has been sequenced — a finding they say could help fight the deadly disease. Doctors...
FDA Issues Draft Guidance on the Judicious Use of Medically Important Antimicrobials in Food-Producing Animals
PR Newswire
PR Newswire
Download image...
Cempra Pharmaceuticals Presents New Data on Its Multi-Drug Resistant Anti-Infective Portfolio, CEM-101 and TAKSTA(TM) (CEM-102), at the 20th European Congress of Clinical Microbiology and Infectious Disease
PR Newswire
PR Newswire
-- Phase 1 multi-dose study of oral CEM-101, a macrolide, shows excellent tolerability and potential for once-daily dosing -- Data on in vitro activity of CEM-101 show broad spectrum of activity and high...
Drug-resistant strain of E. coli emerges in U.S.
MSNBC
MSNBC
WASHINGTON — A new, virulent and drug-resistant strain of E. coli bacteria is infecting people in the United States and posing a significant public health threat, doctors reported on Friday. The new strain is...
Duke steps up superbug program
The News & Observer
The News & Observer
The best defense against a deadly superbug might be a virtual offense. Duke University researchers are expanding upon a computer program they invented last year to predict how a rapidly mutating, infectious bacterium...
Cempra Announces the Completion of Phase 1 Studies for CEM-101, a Next-Generation Macrolide
PR Newswire
PR Newswire
-- Phase 2 Trial with Oral Capsules in Community-Acquired Bacterial Pneumonia Expected to Begin Enrollment During Second Quarter --Phase 1 IND for Intravenous (IV) Formulation to be Submitted Mid-2010...


